These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 18606372)

  • 1. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
    Walk EE
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of highly personalized health care.
    Robson B; Garnier J
    Stud Health Technol Inform; 2002; 80():163-74. PubMed ID: 12026125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
    Issa AM
    Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.
    Bissonnette L; Bergeron MG
    Expert Rev Mol Diagn; 2006 May; 6(3):433-50. PubMed ID: 16706745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Companion diagnostics: significances and issues in its clinical application].
    Miyachi H
    Rinsho Byori; 2011 Jun; 59(6):602-9. PubMed ID: 21815484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenge of personalized health care: to what extent is medicine already individualized and what are the future trends?
    Fierz W
    Med Sci Monit; 2004 May; 10(5):RA111-23. PubMed ID: 15114285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends in genetic-based medical diagnostics.
    Robinson K
    Clin Leadersh Manag Rev; 2005 May; 19(3):E2. PubMed ID: 15927094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Educating for personalized medicine: a perspective from oncology.
    Parkinson DR; Ziegler J
    Clin Pharmacol Ther; 2009 Jul; 86(1):23-5. PubMed ID: 19536120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.
    Ross JS; Ginsburg GS
    Expert Rev Mol Diagn; 2002 Nov; 2(6):531-41. PubMed ID: 12465450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D; Rehavi M
    Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
    Ross JS; Ginsburg GS
    Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foundations, promises and uncertainties of personalized medicine.
    Bottinger EP
    Mt Sinai J Med; 2007 Apr; 74(1):15-21. PubMed ID: 17516562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine prompts push to redesign clinical trials.
    Singer E
    Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
    [No Abstract]   [Full Text] [Related]  

  • 19. Individual genomes instead of race for personalized medicine.
    Ng PC; Zhao Q; Levy S; Strausberg RL; Venter JC
    Clin Pharmacol Ther; 2008 Sep; 84(3):306-9. PubMed ID: 18714319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of pharmacogenomics for drug development and clinical practice.
    Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
    Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.